Literature DB >> 15695086

ETV6-NTRK3 gene fusion in a secretory carcinoma of the breast of a male-to-female transsexual.

F Grabellus1, K Worm, A Willruth, K J Schmitz, F Otterbach, H A Baba, R Kimmig, K A Metz.   

Abstract

Secretory carcinomas of the breast were first described as "juvenile carcinoma" by McDivitt and Stewart in a cohort of children. This term has been replaced by the term "secretory breast carcinoma", because the entity can occur at any time of life. Carcinoma of the male breast is uncommon and accounts for approximately 1% of all cancers in men. Recently, it has been reported that human secretory breast carcinoma expresses the ETV6-NTRK3 gene fusion that was previously cloned in pediatric mesenchymal cancers. We present the case of a 46-year-old male-to-female transsexual in whom a secretory breast carcinoma was an incidental finding. As confirmation of the histopathological diagnosis we detected the novel ETV6-NTRK3 gene fusion in this tumor.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15695086     DOI: 10.1016/j.breast.2004.04.005

Source DB:  PubMed          Journal:  Breast        ISSN: 0960-9776            Impact factor:   4.380


  10 in total

1.  A rare case of secretory breast carcinoma in a male adult with axillary lymph node metastasis.

Authors:  Jinhua Ding; Li Jiang; Yongli Gan; Weizhu Wu
Journal:  Int J Clin Exp Pathol       Date:  2015-03-01

2.  Breast cancer in male-to-female (MtF) transgender patients: is hormone receptor negativity a feature?

Authors:  Zhi Hao Teoh; David Archampong; Tim Gate
Journal:  BMJ Case Rep       Date:  2015-05-20

Review 3.  Cancer in Transgender People: Evidence and Methodological Considerations.

Authors:  Hayley Braun; Rebecca Nash; Vin Tangpricha; Janice Brockman; Kevin Ward; Michael Goodman
Journal:  Epidemiol Rev       Date:  2017-01-01       Impact factor: 6.222

Review 4.  Interdisciplinary Management of Transgender Individuals at Risk for Breast Cancer: Case Reports and Review of the Literature.

Authors:  Julia Eismann; Yujing J Heng; Kristin Fleischmann-Rose; Adam M Tobias; Jordana Phillips; Gerburg M Wulf; Kari J Kansal
Journal:  Clin Breast Cancer       Date:  2018-11-14       Impact factor: 3.225

5.  BRCA2-associated Breast Cancer in Transgender Women: Reconstructive Challenges and Literature Review.

Authors:  Naomi A Cole; Libby R Copeland-Halperin; Nina Shank; Vidya Shankaran
Journal:  Plast Reconstr Surg Glob Open       Date:  2022-04-22

6.  Secretory carcinoma of the breast containing the ETV6-NTRK3 fusion gene in a male: case report and review of the literature.

Authors:  C Arce; D Cortes-Padilla; D G Huntsman; M A Miller; A Dueñnas-Gonzalez; A Alvarado; V Pérez; D Gallardo-Rincón; F Lara-Medina
Journal:  World J Surg Oncol       Date:  2005-06-17       Impact factor: 2.754

7.  Hormone therapy in transgender adults is safe with provider supervision; A review of hormone therapy sequelae for transgender individuals.

Authors:  Jamie D Weinand; Joshua D Safer
Journal:  J Clin Transl Endocrinol       Date:  2015-06

8.  Secretory carcinoma of male breast: case report and review of the literature.

Authors:  S Gabal; S Talaat
Journal:  Int J Breast Cancer       Date:  2011-02-06

9.  Secretory Carcinoma of the Breast: Report of Two Cases and Review of the Literature.

Authors:  Vivekanand Sharma; Gajendra Anuragi; Suresh Singh; Pinakin Patel; Arpita Jindal; Raj Govind Sharma
Journal:  Case Rep Oncol Med       Date:  2015-07-05

10.  Mammary Myofibroblastoma in a Transgender Patient on Feminizing Hormones: Literature Review and Case Report.

Authors:  Jane O'Bryan; Carolyn Wolf-Gould; Yoshiro Matsuo
Journal:  Transgend Health       Date:  2018-01-01
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.